3446 Stock Overview
JTEC Corporation designs, manufactures, and sells X-ray mirrors for synchrotron facilities in Japan.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 5/6 |
Past Performance | 3/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
JTEC Corporation Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | JP¥2,080.00 |
52 Week High | JP¥2,920.00 |
52 Week Low | JP¥1,731.00 |
Beta | 1.12 |
1 Month Change | 6.45% |
3 Month Change | -10.27% |
1 Year Change | -18.27% |
3 Year Change | -28.28% |
5 Year Change | -57.64% |
Change since IPO | -59.85% |
Recent News & Updates
Recent updates
Shareholder Returns
3446 | JP Medical Equipment | JP Market | |
---|---|---|---|
7D | 4.3% | -2.2% | -4.7% |
1Y | -18.3% | 8.6% | 26.3% |
Return vs Industry: 3446 underperformed the JP Medical Equipment industry which returned 8.6% over the past year.
Return vs Market: 3446 underperformed the JP Market which returned 26.3% over the past year.
Price Volatility
3446 volatility | |
---|---|
3446 Average Weekly Movement | 5.4% |
Medical Equipment Industry Average Movement | 3.9% |
Market Average Movement | 4.1% |
10% most volatile stocks in JP Market | 8.2% |
10% least volatile stocks in JP Market | 2.2% |
Stable Share Price: 3446 has not had significant price volatility in the past 3 months.
Volatility Over Time: 3446's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1993 | 64 | Takashi Tsumura | www.j-tec.co.jp |
JTEC Corporation designs, manufactures, and sells X-ray mirrors for synchrotron facilities in Japan. The company designs, develops, manufactures, and sells automated cell culture systems, as well as automated systems in various fields. It offers support services related to regenerative medicine.
JTEC Corporation Fundamentals Summary
3446 fundamental statistics | |
---|---|
Market cap | JP¥11.72b |
Earnings (TTM) | JP¥177.00m |
Revenue (TTM) | JP¥1.92b |
69.1x
P/E Ratio6.4x
P/S RatioIs 3446 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
3446 income statement (TTM) | |
---|---|
Revenue | JP¥1.92b |
Cost of Revenue | JP¥780.00m |
Gross Profit | JP¥1.14b |
Other Expenses | JP¥963.00m |
Earnings | JP¥177.00m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 14, 2024
Earnings per share (EPS) | 30.11 |
Gross Margin | 59.38% |
Net Profit Margin | 9.22% |
Debt/Equity Ratio | 23.9% |
How did 3446 perform over the long term?
See historical performance and comparison